Sign up

Pharma M&A versus Alliances and its Underlying Value Drivers: Are M&A or Alliances the Right Therapy for an Ailing Pharmaceutical Industry?- A Capital Market Perspective

Book
0
Ratings0
Reviews0
Followers0
Q's
Pharma M&A versus Alliances and its Underlying Value Drivers: Are M&A or Alliances the Right Therapy for an Ailing Pharmaceutical Industry?- A Capital Market Perspective
Pharma M&A versus Alliances and its Underlying Value Drivers: Are M&A or Alliances the Right Therapy for an Ailing Pharmaceutical Industry?- A Capital Market Perspective
Highlights Images Videos
No Media

This item doesn’t have any media yet

Add New Image or Add New Video
Pharma M&A versus Alliances and its Underlying Value Drivers: Are M&A or Alliances the Right Therapy for an Ailing Pharmaceutical Industry?- A Capital Market Perspective

2015 | Business & Finance

From a capital market perspective, the author analyzes Merger and Acquisitions transactions (M&A) and in-licensings in the pharmaceutical industry between 1998 and 2012. Utilizing the event study methodology, the volume shows that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. But what are the underlying value drivers which make a deal a success or a failure story? The author derives significant innovative determinants of success for both strategies.

Related Items:
No related items currently exists - add one now
Heiko Schon
Published by Peter Lang AG
Edition Unknown
ISBN 9783631663813
Language N/A

Images And Data Courtesy Of: Peter Lang AG.
This content (including text, images, videos and other media) is published and used in accordance with Fair Use.

Added By
Edit this item to be credited with its creation